Open Access Email this article to a friend

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

Liv Jonsson*, Alexander Gaber, David Ulmert, Mathias Uhlén, Anders Bjartell and Karin Jirström

Diagnostic Pathology 2011, 6:91 doi:10.1186/1746-1596-6-91

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Diagnostic Pathology's emails?